{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:54:21Z","timestamp":1785596061789,"version":"3.56.0"},"reference-count":11,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We developed and validated sensitive MS\/MS methods for the determination of venetoclax, an oral selective B\u2010cell lymphoma\u20102 inhibitor, in human plasma and cerebrospinal fluid (CSF). Acetonitrile was used as protein precipitant. The mobile phase was 10\u00a0mM ammonium formate consisting of 0.1% formic acid and acetonitrile (40:60, v\/v). The analytes were separated on an ACQUITY UPLC HSS T3 column (2.1\u2009\u00d7\u200950\u2009mm, 1.8\u00a0\u03bcm) in 5\u00a0min. An API 4000 mass spectrometer was selected to quantify venetoclax and internal standard using <jats:italic>m<\/jats:italic>\/<jats:italic>z<\/jats:italic> 868.3\u2009\u2192\u2009636.3 and 876.3\u2009\u2192\u2009644.3 under multiple response monitoring mode. In plasma, the calibration curve exhibited good linearity ranging from 20.0 to 5000\u2009ng\/mL, whereas in the CSF, the linear range was 0.500\u2013100\u2009ng\/mL. The matrix effect of venetoclax and internal standard (venetoclax\u2010d8) was not obvious in both plasma and CSF. The inter\u2010 and intra\u2010run accuracy was within \u00b111.9%, and the inter\u2010 and intra\u2010run precision was below 13.6%. Both methods had no carryover, and the recovery was close to 100%. The validated methods were employed to quantify the concentrations of venetoclax in the plasma and CSF of patients diagnosed with chronic lymphocytic leukemia or acute myelogenous leukemia.<\/jats:p>","DOI":"10.1002\/bmc.5738","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T02:58:46Z","timestamp":1695092326000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["LC\u2013MS\/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid"],"prefix":"10.1002","volume":"37","author":[{"given":"Yan\u2010Ling","family":"Yang","sequence":"first","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou\u2010Yi","family":"Qian","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang\u2010Long","family":"Chen","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong\u2010Ye","family":"Huang","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Jiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u2010Ning","family":"Sun","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-5329","authenticated-orcid":false,"given":"Yong\u2010Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China"},{"name":"School of Pharmacy Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210220"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04179-w"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.858"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1761964"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26083"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060463"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2018.02.002"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.213157"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-019-00673-1"},{"key":"e_1_2_8_11_1","unstructured":"U.S. Department of Health and Human Services. (2022).Bioanalytical method validation guidance for industry.https:\/\/www.fda.gov\/media\/70858\/download"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27051607"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.5738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:08:21Z","timestamp":1760040501000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.5738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1002\/bmc.5738"],"URL":"https:\/\/doi.org\/10.1002\/bmc.5738","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"2023-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e5738"}}